RUNX1 and oral cavity squamous cell carcinoma: Research by Jain et al. demonstrated that RUNX1 potentially promoted stem cell activation in hair follicle stem cells and skin and oral squamous cell carcinoma through the regulation of lipid metabolism and its impact on the Wnt signaling pathway [122].